Altimmune, Inc. (ALT)
NASDAQ: ALT · Real-Time Price · USD
2.730
+0.020 (0.74%)
At close: Jun 8, 2026, 4:00 PM EDT
2.790
+0.060 (2.20%)
Pre-market: Jun 9, 2026, 5:22 AM EDT
Altimmune Stock Forecast
ALT's stock price has decreased by -51.42% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
According to 10 analysts polled by S&P Global, Altimmune stock has a consensus rating of "Buy" and an average price target of $16.06. The average 1-year stock price forecast is 488.28% higher than the current stock price, while the lowest is $2.50 (-8.42%) and the highest is $28 (+925.64%).
Price Target: $16.06 (+488.28%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Altimmune stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 6 | 6 | 6 | 6 |
| Buy | 3 | 3 | 3 | 3 | 2 | 2 |
| Hold | 1 | 1 | 1 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 1 | 1 | 1 | 0 | 0 | 0 |
| Total | 10 | 10 | 11 | 11 | 10 | 10 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| H.C. Wainwright | H.C. Wainwright | Buy Maintains $20 | Buy | Maintains | $20 | +632.60% | Jun 4, 2026 |
| Truist Financial | Truist Financial | Buy Maintains n/a | Buy | Maintains | n/a | n/a | May 29, 2026 |
| Citizens JMP | Citizens JMP | Buy Maintains $14 → $11 | Buy | Maintains | $14 → $11 | +302.93% | May 14, 2026 |
| Barclays | Barclays | Buy Maintains $20 | Buy | Maintains | $20 | +632.60% | May 14, 2026 |
| William Blair | William Blair | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | May 13, 2026 |
Financial Forecast
Revenue This Year
4.56K
from 41.00K
Decreased by -88.88%
Revenue Next Year
n/a
from 4.56K
Decreased by -100.00%
EPS This Year
-0.74
from -1.00
EPS Next Year
-0.90
from -0.74
EPS and Forward PE are based on non-GAAP adjusted numbers.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 41,000 | ||
| Avg | 4,560 | ||
| Low | n/a |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | ||
| Avg | -88.9% | ||
| Low | -100.0% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | ||
| Avg | -0.74 | ||
| Low | - |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | ||
| Avg | - | ||
| Low | - |